ClinicalTrials.Veeva

Menu

Striving Towards EmPowerment and Medication Adherence R01

University of Miami logo

University of Miami

Status

Enrolling

Conditions

Mental Health Issue
Hiv

Treatments

Behavioral: Enhanced treatment as usual (E-TAU)
Behavioral: STEP-AD

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06463886
R01MH135833 (U.S. NIH Grant/Contract)
20230854

Details and patient eligibility

About

This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines

Enrollment

250 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Black
  2. Living with HIV
  3. Cis-gender female
  4. Age 18 or older
  5. English speaking
  6. Viral load non-suppression (>200 ml) within the past year or a lack of HIV viral load measure for 6 consecutive months or more during the past 12 months
  7. History of trauma/abuse
  8. Capable of completing and fully understanding the informed consent process and study procedures

Exclusion criteria

  1. Unable to completely and fully understand the informed consent process and the study procedures
  2. Significantly interfering mental health symptoms (e.g., active psychosis that is untreated)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

250 participants in 2 patient groups

STEP-AD
Experimental group
Description:
Participants in this arm will receive the manualized 10 session behavioral medicine intervention titled "Striving Towards EmPowerment and Medication Adherence". Participants will be in this group for a total of up to 1.5 years.
Treatment:
Behavioral: STEP-AD
Enhanced treatment as usual
Active Comparator group
Description:
Participants in the comparison condition will also complete 10 in person sessions. The first session will consist of a session on healthy living with HIV. The remaining 9 sessions will consist of neutral (daily events) writing. Participants will be in this group for a total of up to 1.5 years.
Treatment:
Behavioral: Enhanced treatment as usual (E-TAU)

Trial contacts and locations

1

Loading...

Central trial contact

Shine Research; Sannisha Dale, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems